Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 11Neoplasms 8Carcinoid Tumor 7Diarrhea 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 5Vipoma 4Stomach Neoplasms 4Somatostatinoma 4Rectal Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Islet Cell 4Breast Neoplasms 4Adenoma, Islet Cell 4Acromegaly 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Intestinal Obstruction 3Gastrinoma 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma 3Thymoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Meningioma 2

Interventions

Colonoscopy 16Water 3Aspirin 3Ursodeoxycholic Acid 2Sunitinib 2Narrow Band Imaging 2Folic Acid 2Endoscopic Mucosal Resection 2Calcium Carbonate 2pegvisomant 1defactinib 1S-Adenosylmethionine 1Reference Standards 1Polyethylene Glycols 1Octreotide 1Occult Blood 1Methods 1Mesalamine 1Mass Screening 1Injections 1Indocyanine Green 1Endoscopy 1Drug Evaluation 1Diet, Fat-Restricted 1Diagnostic Tests, Routine 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcitriol 1Cabergoline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenoma × Octreotide × Clear all
NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

AdventHealth

Phase 4 Terminated
33 enrolled

Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡